A new discovery from a team led by Massachusetts Eye and Ear researchers may bring scientists a step closer to developing treatments that regrow the lost cells that cause hearing loss.
VISTASEAL Fibrin Sealant to Quickly Stop Surgical Bleeds
Ethicon, a part of J&J, is releasing a new surgical fibrin sealant designed to be delivered much faster than existing options. The VISTASEAL Fibrin Sealant helps to control unexpected bleeding thanks to its chemical composition and delivery mechanism, which work together to quickly get to the bleed site and achieve hemostasis faster. VISTASEAL (Read more...)
Aerie seeks European marketing authorization for Roclanda
Aerie Pharmaceuticals has submitted a marketing authorization application for Roclanda to the European Medicines Agency, according to a press release.Roclanda (netarsudil 0.02% and latanoprost 0.005% ophthalmic solution), known as Rocklatan in the Unit…
J-code activations simplify billing reimbursements for practices
Several CMS-designated permanent and product-specific J-codes recently went into effect, allowing three ophthalmology-minded pharmaceutical companies to expand reimbursement through commercial and Medicare insurance plans.J-codes were activated Oct. 1 …
Dr. Hugh Herr, Founder of BionX: On The Superpowers of Bionic Technologies
Two young and extremely talented rock and ice climbers set out to summit Mt. Washington, the highest peak in the Northeastern United States (6,288 feet) and considered to be the world’s most dangerous small mountain, in January of 1982. Despite careful planning, an unfortunate turn in the weather caused Hugh Herr and his friend Jeff [… (Read more...)
Reproxalap demonstrates positive phase 3 results for dry eye
Topical ocular reproxalap improved ocular dryness more than vehicle in the first part of a phase 3 trial, Aldeyra Therapeutics announced in a press release.The ongoing, adaptive, two-part, multicenter, randomized, vehicle-controlled, double-masked, par…